TC
INSIDER · SYRE · Spyre Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER
Turtle Cameron
Every open-market transaction filed under this name, Sep 1 to Sep 1.
Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 400 | $89.07 | $36K | −0.1% |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 3,700 | $88.06 | $326K | +1.0% |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 8,400 | $87.15 | $732K | +2.1% |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 2,500 | $86.36 | $216K | +3.0% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.